Cargando…

COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients

Detalles Bibliográficos
Autores principales:	Baughman, Robert P., Lower, Elyse E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288208/ https://www.ncbi.nlm.nih.gov/pubmed/34316261 http://dx.doi.org/10.36141/svdld.v38i2.11646

Ejemplares similares

Goldilocks, vitamin D and sarcoidosis
por: Baughman, Robert P, et al.
Publicado: (2014)

Accuracy of Serial PET-CT Imaging in Systemic Sarcoidosis
por: Carbone, Roberto G., et al.
Publicado: (2014)

Dual Medical Therapy for Treatment of Arrhythmias in Cardiac Sarcoidosis
por: Sibilia, Robert, et al.
Publicado: (2022)

Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel
por: Zhou, Ying, et al.
Publicado: (2015)

Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017)

COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities
por: Manansala, Michael, et al.
Publicado: (2021)

Clinical characteristics of sarcoidosis patients in the United States versus China
por: Zhou, Ying, et al.
Publicado: (2017)

World Association for Sarcoidosis and Other Granulomatous Disease (WASOG) Centers of Excellence
por: Baughman, Robert P, et al.
Publicado: (2021)

SACE and IL-2R as serum biomarkers for evaluation of multi-organ involvement and prognosis of sarcoidosis
por: Zhou, Ying, et al.
Publicado: (2023)

Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period
por: Baughman, Robert P., et al.
Publicado: (2020)

Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire
por: Baughman, Robert P., et al.
Publicado: (2020)

Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial
por: Baughman, Robert P, et al.
Publicado: (2021)

Investigation of sarcoidosis patients during COVID-19 pandemic
por: Kiani, Arda, et al.
Publicado: (2020)

Cryptococcus and Coccidioides in Sarcoidosis
por: Kenyon, Chris R
Publicado: (2018)

Subcutaneous sarcoidosis on the digits
por: Norikawa, Natsumi, et al.
Publicado: (2020)

Tattoo induced sarcoidosis
por: D’Alessandro, Roberto, et al.
Publicado: (2021)

Pulmonary hypertension associated with sarcoidosis
por: Baughman, Robert P
Publicado: (2007)

Subcutaneous sarcoidosis: a report of 13 cases and its association with extracutaneous sarcoidosis
por: Yamamoto, Toshiyuki
Publicado: (2020)

Sarcoidosis: patient treatment priorities
por: Baughman, Robert P., et al.
Publicado: (2018)

Initial behaviors and attitudes towards the COVID-19 vaccine in sarcoidosis patients: Results of a self-reporting questionnaire
por: Vagts, Christen, et al.
Publicado: (2023)

Pulmonary Streptomyces Infection in Patient with Sarcoidosis, France, 2012
por: Riviere, Etienne, et al.
Publicado: (2012)

Efzofitimod: a novel anti-inflammatory agent for sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2023)

Sandostatin therapy in patients with chronic sarcoidosis
por: Timmermans, Wilhelmina M.C., et al.
Publicado: (2017)

Serpiginoid choroiditis, tuberculosis, and sarcoidosis
por: Joob, Beuy, et al.
Publicado: (2019)

Autoimmunity in sarcoidosis: the tip of the Iceberg
por: Papadopoulos, Konstantinos I., et al.
Publicado: (2022)

Editorial: Diagnosis and treatment of sarcoidosis
por: Zhou, Ying, et al.
Publicado: (2023)

A Case of Sarcoidosis Presenting as Livedo
por: Shibama, Sayaka, et al.
Publicado: (2014)

Central nervous system involvement in sarcoidosis
por: Machado, Vinicius Silles, et al.
Publicado: (2015)

Bone and Bone Marrow Involvement in Sarcoidosis
por: Sargın, Gökhan, et al.
Publicado: (2014)

Hypercalcemic Encephalopathy as the Presenting Manifestation of Sarcoidosis
por: Kumar Prusty, B. Saroj, et al.
Publicado: (2019)

Comment on ‘Management of Cardiac Sarcoidosis in 2020’
por: Korovesis, Socrates, et al.
Publicado: (2021)

Multimodal approach for isolated cardiac sarcoidosis
por: Godo, Shigeo, et al.
Publicado: (2022)

The challenging diagnosis of isolated cardiac sarcoidosis
por: Kupari, Markku
Publicado: (2022)

Risk of death in patients with progressive pulmonary sarcoidosis
por: Bargagli, Elena, et al.
Publicado: (2017)

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2022)

Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study
por: Rahaghi, Franck F., et al.
Publicado: (2020)

Sarcoidosis presenting with acute respiratory distress syndrome
por: Tamura, Tomohiro, et al.
Publicado: (2016)

Sarcoidosis limbic encephalitis: A case report
por: Toudou-Daouda, Moussa, et al.
Publicado: (2017)

Sarcoidosis: when the initial manifestations are musculoskeletal symptoms
por: Reis, Lara Marinho, et al.
Publicado: (2018)

Chylothorax due to sarcoidosis: A unique occurrence
por: Gupta, Abhishek, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5v17dp23bhutq5rd80g8r6qg9e